XOMA Royalty (XOMA) Net Margin (2011 - 2026)

XOMA Royalty (XOMA) reported Net Margin of 36.25% for Q1 2026, down 2293.0% on a YoY basis from 1.65% in Q1 2025, and down 45.42% sequentially from 66.42% in Q4 2025.

XOMA Royalty (XOMA) Net Margin (2011 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 16 years of Net Margin data on file, last reported at 36.25% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 2293.0% year-over-year to 36.25%; the trailing twelve-month figure through Mar 2026 stood at 7.09% (up 31503.0% YoY), and the FY2025 full-year result was 60.81%, up 26762.0% from the prior year.
  • Net Margin slipped to 36.25% in Q1 2026, from 66.42% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 66.42% in Q4 2025 to a low of 5593.78% in Q3 2023.
  • A 5-year average of 1390.05% and a median of 730.17% in 2024 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin tumbled 1566409 bps in 2022 and surged 535419 bps in 2024, its largest moves.
  • Tracing XOMA's Net Margin over 5 years: stood at 736.59% in 2022, then slumped by 112 bps to 1565.23% in 2023, then slipped by 22 bps to 1911.6% in 2024, then soared by 103 bps to 66.42% in 2025, then sank by 45 bps to 36.25% in 2026.
  • Business Quant data shows XOMA's Net Margin at 36.25% in Q1 2026, 66.42% in Q4 2025, and 221.13% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - 36.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 36.25%
Dec 31, 2025 66.42%
Jun 30, 2025 -221.13%
Mar 31, 2025 59.18%
Dec 31, 2024 -1,911.60%
Sep 30, 2024 -239.59%
Jun 30, 2024 -538.49%
Mar 31, 2024 -723.76%
Dec 31, 2023 -1,565.23%
Sep 30, 2023 -5,593.78%
Jun 30, 2023 -1,048.67%
Mar 31, 2023 -2,532.49%
Dec 31, 2022 -736.59%
Sep 30, 2022 -3,249.67%
Jun 30, 2022 -3,964.76%
Mar 31, 2022 -76.91%
Dec 31, 2021 14,927.50%
Sep 30, 2021 -806.55%
Jun 30, 2021 -248.28%
Mar 31, 2021 -1,966.13%